Authors
Loading...
Experiment shows type I interferon and neutrophil extracellular traps are linked to lung injury in sickle cell disease, suggesting TLR9 is a therapeutic target.
Sivanantham et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: